Efficacy and Safety of Dapagliflozin in Children With Inherited Proteinuric Kidney Disease: A Pilot Study

• Jiaojiao Liu,
• Jingyi Cui,
• Xiaoyan Fang,
• Jing Chen,
• Weili Yan,
• Qian Shen,
• Hong Xu

Affiliations

Jiaojiao Liu

Department of Nephrology, Children’s Hospital of Fudan University, National Paediatric Medical Center of China, Shanghai, China

Jingyi Cui

Department of Nephrology, Children’s Hospital of Fudan University, National Paediatric Medical Center of China, Shanghai, China

Xiaoyan Fang

Department of Nephrology, Children’s Hospital of Fudan University, National Paediatric Medical Center of China, Shanghai, China

Jing Chen

Department of Nephrology, Children’s Hospital of Fudan University, National Paediatric Medical Center of China, Shanghai, China

Weili Yan

Department of Clinical Epidemiology, Children’s Hospital of Fudan University, National Paediatric Medical Center of China, Shanghai, China

Qian Shen

Department of Nephrology, Children’s Hospital of Fudan University, National Paediatric Medical Center of China, Shanghai, China; Qian Shen, Department of Nephrology, Children’s Hospital of Fudan University, National Paediatric Medical Center of China, Shanghai, China.

Hong Xu

Department of Nephrology, Children’s Hospital of Fudan University, National Paediatric Medical Center of China, Shanghai, China; Correspondence: Hong Xu, Department of Nephrology, Children’s Hospital of Fudan University, National Paediatric Medical Center of China, Shanghai, China.